Drawing for XELPROS

USPTO serial 86194809

XELPROS

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
DUBRAY, KATHERINE M
Law office
TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XELPROS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Oral contraceptivesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 25, 2015MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Jun 25, 2015ABN1ABANDONMENT - EXPRESS MAILED—
Jun 25, 2015EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 30, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 30, 2015GNSLLETTER OF SUSPENSION E-MAILED—
May 30, 2015CNSLSUSPENSION LETTER WRITTEN—
May 13, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 13, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 9, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 14, 2015GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 14, 2015GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 14, 2015CNSISUSPENSION INQUIRY WRITTEN—
Jan 13, 2015RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 7, 2015ALIEASSIGNED TO LIE—
May 28, 2014GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 28, 2014GNSLLETTER OF SUSPENSION E-MAILED—
May 28, 2014CNSLSUSPENSION LETTER WRITTEN—
May 22, 2014DOCKASSIGNED TO EXAMINER—
Feb 27, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 19, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance